NANONOX
DEAD

Serial Number

90070160

Owner

NeoVirucide, Inc.

Attorney

Roger Fidler

Filing Date

Jul 23, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NANONOX Trademark

Serial Number: 90070160

NANONOX is a trademark filed by NeoVirucide, Inc. on July 23, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NeoVirucide, Inc.

1522 Gardner Drive
Lutz, FL 33559

Entity Type: 03

Trademark Details

Filing Date

July 23, 2020

Registration Date

Not Registered

Published for Opposition

December 15, 2020

Goods & Services

Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of fungal infections; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, inducers of erections; Antibacterial pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 13, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 13, 2021 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 9, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 15, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 15, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 25, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 9, 2020 CNSA
ASSIGNED TO EXAMINER
Nov 7, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2020 NWOS
NEW APPLICATION ENTERED
Jul 27, 2020 NWAP